Albert Joseph Rogers, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rogers’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A137617 · Current
Licensed to practise in California · since 2015 · expires 2028-11-30 · University of North Carolina at Chapel Hill.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$134,244
Medicare paid this office $134,244 for 1,964 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 42 | $33,561 | $780 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,430 | $12,840 | $7 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 31 | $9,872 | $253 |
| Long return visit (40+ min) | 41 | $7,415 | $154 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $7,113 | $445 |
See all 21 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 42 | $33,561 | $780 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,430 | $12,840 | $7 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 31 | $9,872 | $253 |
| Long return visit (40+ min) | 41 | $7,415 | $154 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $7,113 | $445 |
| Long return visit (40+ min) | 50 | $6,637 | $125 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 199 | $4,542 | $22 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 12 | $4,303 | $253 |
| Return visit (30+ min) | 22 | $2,967 | $124 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 85 | $2,617 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,318 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,116 | $106 |
| New patient visit (45+ min) | 19 | $1,922 | $101 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,827 | $96 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 29 | $1,325 | $29 |
| Return visit (30+ min) | 15 | $1,315 | $88 |
| Programming of dual lead pacemaker system | 30 | $1,208 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 63 | $882 | $14 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 20 | $390 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 31 | $198 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $188 | $10 |
Procedures Medicare counted
| Pacemaker insertion or repair | 26 | More than 76% of doctors who do this |
Who their Medicare patients are
1,964 Original Medicare patients in 2024. Average age 76 · Under 65 8% · 85 and older 18% · Women 51% · Also on Medicaid 28% · Health risk score 2.15. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 49% · Coronary heart disease 48% · Heart failure 43% · Chronic kidney disease 42% · Diabetes 37% · Depression 25% · Cancer 24% · COPD 20% · Stroke 18% · Dementia 16%.
The office billed $1,155,229, Medicare allowed $172,736 and paid $134,244; for 2,837 services of 55 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,964 | 2,837 | 76 | 2.15 | $1,155,229 | $134,244 |
| 2023 | 2,226 | 3,560 | 75 | 2.20 | $1,008,057 | $133,754 |
| 2022 | 610 | 859 | 74 | 2.04 | $207,259 | $32,039 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 27 | $21,828 | $808 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,767 | $18,338 | $7 |
| Long return visit (40+ min) | 99 | $14,316 | $128 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 23 | $10,419 | $453 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 187 | $4,232 | $22 |
| New patient visit (60+ min) | 26 | $4,080 | $157 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,622 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,323 | $107 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 11 | $3,142 | $262 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 64 | $2,316 | $26 |
| Programming of dual lead pacemaker system | 44 | $1,662 | $33 |
| Return visit (30+ min) | 15 | $1,500 | $83 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,440 | $72 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 26 | $1,364 | $32 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,360 | $105 |
| New patient visit (45+ min) | 11 | $1,042 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $855 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 54 | $788 | $14 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 30 | $656 | $21 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | $595 | $28 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 15 | $70 | $5 |
2022: 7 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $7,342 | $459 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 507 | $4,912 | $7 |
| Long return visit (40+ min) | 15 | $2,114 | $132 |
| New patient visit (60+ min) | 12 | $1,985 | $165 |
| New patient visit (45+ min) | 11 | $1,217 | $111 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $976 | $81 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $391 | $24 |
Medicaid work
$12,148 in 2024
Medicaid paid $12,148 for 1,228 billed services this clinician did in 2024, up to 163 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,186 | $11,397 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 42 | $751 |
| 2024 | 1,228 | 2 | 163 | $12,148 |
| 2023 | 1,999 | 2 | 557 | $19,350 |
| 2022 | 554 | 1 | 346 | $5,417 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,970 | $18,824 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 29 | $525 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 554 | $5,417 |
Drugs they prescribed that Part D paid
$135,971
Pharmacies billed $135,971 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 426) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
308 generic and 118 brand-name prescriptions · $135,971 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 95 | $109,075 | $1,148 |
| Xarelto | 12 | $12,019 | $1,002 |
| Dofetilide | 18 | $2,390 | $133 |
| Flecainide Acetate | 44 | $1,312 | $30 |
| Amiodarone | 34 | $797 | $23 |
See all 10 drugs
| Eliquis | 95 | $109,075 | $1,148 |
| Xarelto | 12 | $12,019 | $1,002 |
| Dofetilide | 18 | $2,390 | $133 |
| Flecainide Acetate | 44 | $1,312 | $30 |
| Amiodarone | 34 | $797 | $23 |
| Metoprolol | 46 | $720 | $16 |
| Metoprolol | 45 | $431 | $10 |
| Diltiazem 24hr Er (Cd) | 12 | $375 | $31 |
| Pantoprazole | 45 | $254 | $6 |
| Atorvastatin | 12 | $95 | $8 |
Year by year
| 2024 | 426 | 107 | 0% (0) | 28% | $135,971 |
| 2023 | 286 | 76 | 0% (0) | 22% | $79,226 |
| 2022 | 42 | 21 | 0% (0) | 29% | $9,141 |
| 2021 | 20 | 12 | None | None | $1,818 |
| 2020 | 24 | 12 | None | None | $1,337 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Eliquis | 44 | $49,607 | $1,127 |
| Flecainide Acetate | 31 | $824 | $27 |
| Metoprolol | 40 | $784 | $20 |
| Metoprolol | 35 | $730 | $21 |
| Amiodarone | 21 | $548 | $26 |
| Pantoprazole | 24 | $199 | $8 |
2022: 1 drug
| Metoprolol | 12 | $44 | $4 |
Money from drug and device companies
$13,489 in 2025
| 2025 | 5 | 74 | $9,385 | $13,489 |
| 2024 | 5 | 41 | None | $3,273 |
| 2023 | 5 | 12 | None | $838 |
| 2022 | 7 | 27 | None | $17,120 |
| 2021 | 4 | 16 | None | $12,040 |
| 2020 | 3 | 29 | None | $11,636 |
| 2019 | 3 | 30 | None | $5,380 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Tacticath Ablation Catheter, Sensor Enabled | $9,233 | 21 payments
|
| Impulse Dynamics (USA) | None | $2,756 | 2 payments
|
| Biosense Webster | Carto 3 | $1,278 | 47 payments
|
| Boston Scientific | General - Therapies | $148 | 2 payments
|
| Medtronic | Linq II | $74 | 2 payments
|
See all 74 published payments
| Biosense Webster | Meals · 2025-12-23 | Carto 3 | $11 |
| Biosense Webster | Meals · 2025-12-19 | Carto 3 | $12 |
| Biosense Webster | Meals · 2025-12-18 | Nuvision Ice Catheter | $98 |
| Boston Scientific | Meals · 2025-12-18 | Rhythmia Mapping System | $66 |
| Biosense Webster | Meals · 2025-12-08 | Carto 3 | $16 |
| Biosense Webster | Meals · 2025-12-05 | Carto 3 | $10 |
| Biosense Webster | Meals · 2025-11-21 | Carto 3 | $18 |
| Biosense Webster | Meals · 2025-10-31 | Carto 3 | $17 |
| Biosense Webster | Meals · 2025-10-29 | Carto 3 | $12 |
| Biosense Webster | Meals · 2025-10-23 | Carto 3 | $17 |
| Biosense Webster | Meals · 2025-10-17 | Carto 3 | $10 |
| Biosense Webster | Meals · 2025-10-07 | Carto 3 | $133 |
| Biosense Webster | Meals · 2025-09-26 | Carto 3 | $15 |
| Biosense Webster | Meals · 2025-09-26 | Carto 3 | $16 |
| Biosense Webster | Meals · 2025-09-19 | Carto 3 | $14 |
| Biosense Webster | Meals · 2025-09-12 | Carto 3 | $11 |
| Abbott Laboratories | Meals · 2025-09-10 | Ensite Precision | $87 |
| Biosense Webster | Meals · 2025-09-08 | Carto 3 | $19 |
| Biosense Webster | Meals · 2025-09-05 | Carto 3 | $18 |
| Abbott Laboratories | Meals · 2025-09-05 | Aveir | $84 |
| Abbott Laboratories | Meals · 2025-09-05 | Aveir | $105 |
| Abbott Laboratories | Meals · 2025-09-05 | Aveir | $63 |
| Abbott Laboratories | Travel · 2025-09-05 | Aveir | $309 |
| Biosense Webster | Meals · 2025-08-29 | Carto 3 | $15 |
| Biosense Webster | Meals · 2025-08-22 | Carto 3 | $10 |
| Abbott Laboratories | Consulting · 2025-08-19 | Tacticath Ablation Catheter, Sensor Enabled | $6,704 |
| Biosense Webster | Meals · 2025-07-30 | Carto 3 | $17 |
| Biosense Webster | Meals · 2025-07-28 | Carto 3 | $9 |
| Biosense Webster | Meals · 2025-07-28 | Carto 3 | $20 |
| Biosense Webster | Meals · 2025-07-25 | Carto 3 | $18 |
| Impulse Dynamics (USA) | Consulting · 2025-07-21 | None | $2,681 |
| Impulse Dynamics (USA) | Meals · 2025-07-21 | None | $75 |
| Biosense Webster | Meals · 2025-07-18 | Carto 3 | $9 |
| Biosense Webster | Meals · 2025-07-16 | Carto 3 | $133 |
| Biosense Webster | Meals · 2025-07-11 | Carto 3 | $12 |
| Biosense Webster | Meals · 2025-07-11 | Carto 3 | $13 |
| Abbott Laboratories | Travel · 2025-07-10 | None | $171 |
| Abbott Laboratories | Meals · 2025-07-08 | Tacticath Ablation Catheter, Sensor Enabled | $17 |
| Abbott Laboratories | Travel · 2025-07-08 | Tacticath Ablation Catheter, Sensor Enabled | $176 |
| Abbott Laboratories | Travel · 2025-07-07 | Tacticath Ablation Catheter, Sensor Enabled | $416 |
| Abbott Laboratories | Travel · 2025-07-07 | Tacticath Ablation Catheter, Sensor Enabled | $366 |
| Biosense Webster | Meals · 2025-07-02 | Carto 3 | $11 |
| Biosense Webster | Meals · 2025-06-27 | Carto 3 | $147 |
| Biosense Webster | Meals · 2025-06-13 | Carto 3 | $6 |
| Biosense Webster | Meals · 2025-06-13 | Carto 3 | $4 |
| Biosense Webster | Meals · 2025-06-09 | Carto 3 | $5 |
| Abbott Laboratories | Travel · 2025-06-04 | Aveir | $28 |
| Abbott Laboratories | Travel · 2025-06-04 | Aveir | $148 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $55 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $120 |
| Biosense Webster | Meals · 2025-05-23 | Carto 3 | $20 |
| Abbott Laboratories | Meals · 2025-05-22 | Ensite Precision | $156 |
| Biosense Webster | Meals · 2025-05-16 | Carto 3 | $7 |
| Biosense Webster | Meals · 2025-05-16 | Carto 3 | $11 |
| Biosense Webster | Meals · 2025-05-16 | Carto 3 | $8 |
| Biosense Webster | Meals · 2025-05-09 | Carto 3 | $22 |
| Biosense Webster | Meals · 2025-05-09 | Carto 3 | $8 |
| Biosense Webster | Meals · 2025-05-09 | Carto 3 | $10 |
| Medtronic | Meals · 2025-04-27 | Linq II | $25 |
| Medtronic | Meals · 2025-04-26 | Linq II | $49 |
| Biosense Webster | Meals · 2025-04-24 | Carto 3 | $110 |
| Boston Scientific | Meals · 2025-04-23 | General - Therapies | $82 |
| Abbott Laboratories | Travel · 2025-04-17 | Aveir | $184 |
| Abbott Laboratories | Travel · 2025-04-17 | Aveir | $9 |
| Biosense Webster | Meals · 2025-04-16 | Carto 3 | $5 |
| Biosense Webster | Meals · 2025-04-10 | Carto 3 | $150 |
| Biosense Webster | Meals · 2025-04-04 | Carto 3 | $12 |
| Abbott Laboratories | Meals · 2025-04-03 | Tacticath Ablation Catheter, Sensor Enabled | $9 |
| Biosense Webster | Meals · 2025-03-28 | Carto 3 | $12 |
| Biosense Webster | Meals · 2025-03-21 | Carto 3 | $9 |
| Biosense Webster | Meals · 2025-03-07 | Carto 3 | $5 |
| Abbott Laboratories | Meals · 2025-02-11 | Tacticath Ablation Catheter, Sensor Enabled | $10 |
| Biosense Webster | Meals · 2025-01-17 | Carto 3 | $12 |
| Abbott Laboratories | Meals · 2025-01-07 | Ensite | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,273
| Medtronic | Evera Mri Xt Dr Surescan | $1,778 | 15 payments
|
| Biosense Webster | Carto 3 | $582 | 15 payments
|
| Abbott Laboratories | Aveir | $496 | 7 payments
|
| Atricure | Synergy Ablation System | $210 | 1 payment
|
| Boston Scientific | None | $208 | 3 payments
|
2023: $838
| Medtronic | Selectsecure | $278 | 2 payments
|
| Abbott Laboratories | Jot Dx | $276 | 4 payments
|
| Biosense Webster | Carto 3 | $189 | 4 payments
|
| Boston Scientific | None | $66 | 1 payment
|
| Atricure | Synergy Ablation System | $29 | 1 payment
|
2022: $17,120
| AtriCure | Synergy Ablation System | $12,281 | 9 payments
|
| Boston Scientific | Emblem Mri S-Icd | $3,779 | 2 payments
|
| Abbott Laboratories | Ensite Precision | $543 | 10 payments
|
| Medtronic | None | $200 | 1 payment
|
| Biotronik | Acticor 7 Vr-T Dx | $197 | 2 payments
|
| Biosense Webster | Carto 3 | $106 | 2 payments
|
| Kci USA | Activ.A.C. | $14 | 1 payment
|
2021: $12,040
| Medtronic | Micra | $7,702 | 8 payments
|
| Boston Scientific | Emblem | $3,750 | 1 payment
|
| Biotronik | Solia | $403 | 4 payments
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Assist Device | $186 | 3 payments
|
2020: $11,636
| Abbott Laboratories | Agilis Nxt Ep Introducer | $4,592 | 4 payments
|
| Boston Scientific | General - Brady | $3,750 | 1 payment
|
| Medtronic Vascular | None | $3,295 | 24 payments
|
2019: $5,380
| Boston Scientific | General Therapies | $3,608 | 13 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $1,739 | 16 payments
|
| Medtronic Vascular | Visia Af | $33 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1316365133
- Licence
- CA A137617California A137617: Current · expires 2028-11-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-03-29
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.